Press Releases Pila Pharma AB

Equities

PILA

SE0015988274

Market Closed - Nasdaq Stockholm Other stock markets 09:30:00 17/06/2024 pm IST			5-day change	1st Jan Change
4.11 ^SEK	-34.55%		+0.24%	+156.88%

19/04	Pila Pharma Appoints New CEO, Chief Scientific Officer	MT
19/04	Pila Pharma AB Announces Board and Management Appointments	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BioStock: Pila Pharma broadens XEN-D0501 with new indication	31/22/31	AQ
BioStock: Pila Pharma's CEO comments on the Q2 report	30/22/30	AQ
BioStock: Pila Pharma initiates toxicological studies	05/22/05	AQ
BioStock: Deep dive into Pila Pharma's clinical concept	25/22/25	AQ
Pila Pharma - Adjusting For a Capital Injection	03/22/03	AQ
BioStock: Pila Pharma takes XEN-D0501 into pain management	29/22/29	AQ
BioStock: Pila Pharma's CEO on building the company since its IPO	25/22/25	AQ
BioStock: Novo veteran strengthens Pila Pharma	10/22/10	AQ
BioStock: Several triggers for Pila Pharma in 2022	19/22/19	AQ
Redeye Initiates Coverage of Pila Pharma	17/21/17	AQ
BioStock: Pila Pharma enters agreement for toxicological studies	30/21/30	AQ
BioStock: Pila Pharma CEO increases holding	18/21/18	AQ
BioStock: Pila Pharma rounds off first quarter as a publicly traded company	02/21/02	AQ
BioStock: Discovery behind Pila Pharma's leading principle receives Nobel Prize	08/21/08	AQ
BioStock: Pila Pharma takes final steps before toxicology studies	22/21/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer